Ian Hamilton shares his thoughts on the new Drug Use series published yesterday in The Lancet: The global drug problem – change but not progression.
[read the full story...]The global drug problem: who cares? #LxAddictions19
No Responses »
Amphetamine-like stimulant use: what do we know about who uses them and how drug using careers develop?
Harry Sumnall considers a systematic narrative review, which looks at the individual, social and environmental influences that shape key phases in the amphetamine-like stimulant use trajectory
[read the full story...]Novel Psychoactive Substances: bridging the knowledge gap
Derek Tracy takes a first look at the Novel Psychoactive Substances in the UK Project; an NIHR-funded empirical and conceptual review that recommends research priorities in the field.
[read the full story...]Novel Psychoactive Substances: important information for health professionals
Harry Sumnall, Ian Hamilton and Mark Monaghan provide an overview of Novel Psychoactive Substances (NPS) aimed at health professionals and others who work with people who use these new psychoactive substances.
[read the full story...]NICE one? Is NHS guidance on substance misuse fit for purpose?
Ian Hamilton explains why the National Institute for Health and Care Excellence have missed a trick by not updating their 2007 guidance on psychosocial interventions for substance misuse.
[read the full story...]#CannabisMatters conference report
Ian Hamilton presents a short conference report on the #CannabisMatters event, which took place in York on 7th June 2016.
[read the full story...]One new drug a week: club drugs and novel psychoactive substances
Meg Fluharty summarises a recent report from the Royal College of Psychiatrists and explores why novel psychoactive substances and club drugs need a different response from UK treatment providers.
[read the full story...]